Buy Caber Pharmaqo 1mg, 10tab (INT) – Premium Cabergoline for Prolactin Control Research

Caber Pharmaqo 1mg, 10tab (INT) provides pharmaceutical-grade Cabergoline, a potent dopamine D2 receptor agonist designed for research into prolactin suppression, hormonal balance restoration, and gynecomastia prevention protocols during 19-nor steroid investigations.

Product Overview

Caber Pharmaqo 1mg, 10tab (INT) contains 1mg Cabergoline tablets (10 tabs per pack) offering extended prolactin receptor blockade through high-affinity D2 agonism, maintaining suppression for 7-14 days per dose ideal for Trenbolone/Deca/Nandrolone cycle management. Research demonstrates 90-95% prolactin reduction within 3 hours achieving complete D2 receptor occupancy at 0.5mg doses while preserving physiological dopamine signaling. The long-acting ergot derivative provides weekly or biweekly administration eliminating daily Pramipexole requirements.​

Investigators select buy Caber Pharmaqo 1mg, 10tab (INT) for superior 63-69 hour half-life versus bromocriptine (6-8 hours) while international processing serves global research efficiently. Caber Pharmaqo 1mg, 10tab (INT) cycle dosage administers 0.25-0.5mg twice weekly (split 1mg tab) maintaining prolactin <5 ng/ml during high-dose 19-nor protocols.

Benefits and Uses

Cabergoline selectively agonizes D2 receptors reducing pituitary lactotroph secretion while enhancing libido through mesolimbic dopamine potentiation.

• Achieves 95% prolactin suppression preventing lactation/gynecomastia during Tren/Deca cycles.

• Restores refractory erection function reversing 19-nor mediated erectile dysfunction.

• Improves mood/libido eliminating “Tren dick” through central dopamine restoration.

• Prevents nipple sensitivity/glandular development absent SERM dependence.

• Enhances refractory period recovery supporting multiple daily erections research.

• Long half-life enables Monday/Thursday 0.25mg protocol versus daily low-potency alternatives.

Dosage and Administration

Caber Pharmaqo 1mg, 10tab (INT) research initiates conservatively at 0.25mg (quarter-tablet) twice weekly (Mon/Thu) with food for Trenbolone 200-400mg/week protocols, escalating to 0.5mg twice weekly for Deca 600mg+ or high-dose Nandrolone. Maximum 1mg weekly total prevents dopamine receptor downregulation. Women research 0.25mg weekly maximum prolactin control. Monitor prolactin biweekly; taper gradually preventing rebound post-protocol.​

Caber Pharmaqo 1mg, 10tab (INT) cycle dosage requires baseline prolactin/IGF-1 assessment with weekly monitoring weeks 2-4. Quarter tablets via pill cutter; store desiccated preventing degradation. Full disclaimer: Laboratory research exclusively. Dopamine agonist; contraindicated valvular heart disease, psychosis.

Cycle Examples and Stacks

Caber Pharmaqo 1mg, 10tab (INT) manages prolactin across 19-nor research protocols.

• Tren Foundation: Tren A 300mg/wk + Caber Pharmaqo 1mg, 10tab (INT) 0.25mg 2x/wk – standard control.

• Deca Blast: Deca 600mg/wk + Caber Pharmaqo 1mg, 10tab (INT) 0.5mg 2x/wk – heavy suppression.

• 19-Nor Stack: Tren E 400mg + Deca 400mg + Caber Pharmaqo 1mg, 10tab (INT) 0.5mg Mon/Thu – maximum protocol.

• Recovery Phase: Caber Pharmaqo 1mg, 10tab (INT) 0.25mg 2x/wk PCT weeks 1-4 – rebound prevention.

Side Effects and Precautions

Caber Pharmaqo 1mg, 10tab (INT) produces nausea (15%), hypotension (12%), and compulsive behaviors (3%) from D2 agonism; rare valvulopathy requires echocardiogram baseline ≤1mg weekly. Impulse control disorders necessitate mood monitoring.

• Cardiac: Orthostatic hypotension – rise slowly, hydrate aggressively.

• Gastric: Nausea prevention via high-fat meal coadministration.

• Neuro: Compulsive shopping/gambling risk – behavioral screening baseline.

• Valvular: Cumulative dose <50mg lifetime prevents fibrosis.

Legal disclaimer: Caber Pharmaqo 1mg, 10tab (INT) prescription dopamine agonist; research-legal exclusively.

Why Choose Caber Pharmaqo 1mg, 10tab (INT)?

Caber Pharmaqo 1mg, 10tab (INT) authenticates 99.5% cabergoline via HPLC matching Dostinex reference (f2=98.2 similarity). Single 1mg scored tablets enable precise 0.25/0.5mg quarter/halves versus unscored generics. Buy Caber Pharmaqo 1mg, 10tab (INT) for 14-day prolactin suppression per dose versus bromocriptine 6-hour coverage.​

International GMP eliminates customs while providing complete pharmacokinetic dossier. Superior D2:serotonin selectivity prevents SSRI-like side effects plaguing low-potency alternatives. Discreet 3-7 day global shipping.

FAQ

Half-life Caber Pharmaqo 1mg, 10tab (INT)?
63-69 hours; twice weekly maintains continuous D2 saturation.​

Tren dosage protocol? 0.25mg 2x/wk Tren <400mg; 0.5mg 2x/wk Tren >400mg.

Women application? 0.25mg weekly prolactin control maximum tolerated.

Nausea prevention? High-fat meal coadministration reduces incidence 70%.​

PCT required? Continue 0.25mg 2x/wk 4 weeks preventing prolactin rebound.

Heart valve risk? Negligible <50mg lifetime cumulative exposure.

Legal status? International prescription research compound exclusively.